Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

De Groot, Anne S; Einck, Leo; Moise, Leonard; Chambers, Michael; Ballantyne, John; Malone, Robert W; Ardito, Matthew; Martin, William

De Groot, Anne S; Einck, Leo; Moise, Leonard; Chambers, Michael; Ballantyne, John; Malone, Robert W; Ardito, Matthew; Martin, William.

Affiliation

De Groot AS; EpiVax, Inc.; Providence, RI USA; Institute for Immunology and Informatics; University of Rhode Island; Providence, RI USA.

Hum Vaccin Immunother ; 9(9): 1877-84, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23877094

Subject(s)

Biological Warfare Agents; Civil Defense/methods; Communicable Diseases, Emerging/prevention & control; Technology, Pharmaceutical/methods; Vaccines/immunology; Vaccines/isolation & purification; Communicable Diseases, Emerging/immunology; Humans; Time Factors

Key words

H5N1; H7N9; SARS; biothreat; coronavirus; emerging infectious disease; immunoinformatics; medical countermeasure; vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Technology, Pharmaceutical / Civil Defense / Communicable Diseases, Emerging / Biological Warfare Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Hum Vaccin Immunother Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google